Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

More precise, personalized therapies are needed for autoimmune diseases.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Monocytes might be linked to hair loss after COVID-19.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

The ACE1 gene variant doesn't affect long-COVID symptoms.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

About 61% of women who had COVID-19 experienced hair loss afterward.

Social media data can help track and predict COVID-19 symptoms and trends.

Lower LDL-c levels predict higher COVID-19 mortality.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.